IRZION Trademark

Trademark Overview

On Wednesday, April 22, 2009, a trademark application was filed for IRZION with the United States Patent and Trademark Office. The USPTO has given the IRZION trademark a serial number of 79070964. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Monday, April 22, 2019. This trademark is owned by NOVARTIS AG. The IRZION trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention or treatment of diseases and disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in dermatology, oncology, nephrology, hematology, in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the treatment of bacterial diseases; pharmaceutical preparations for the treatment of diabetes, anti-infectives, antivirals, antibiotics and antifungal preparations; vaccines; diagnostic preparations for medical use
irzion

General Information

Serial Number79070964
Word MarkIRZION
Filing DateWednesday, April 22, 2009
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateMonday, April 22, 2019
Registration Number3757829
Registration DateTuesday, March 9, 2010
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 22, 2009

Trademark Statements

Goods and ServicesPharmaceutical preparations for the prevention or treatment of diseases and disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in dermatology, oncology, nephrology, hematology, in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the treatment of bacterial diseases; pharmaceutical preparations for the treatment of diabetes, anti-infectives, antivirals, antibiotics and antifungal preparations; vaccines; diagnostic preparations for medical use
Pseudo MarkIR ZION

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateTuesday, March 22, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCH
Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCH
Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCH

Trademark Events

Event DateEvent Description
Friday, November 15, 2019NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Friday, November 15, 2019DEATH OF INTERNATIONAL REGISTRATION
Friday, October 27, 2017NOTIFICATION PROCESSED BY IB
Saturday, July 8, 2017FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, July 15, 2016REFUSAL PROCESSED BY IB
Thursday, April 7, 2016NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Thursday, April 7, 2016DEATH OF INTERNATIONAL REGISTRATION
Monday, April 15, 2013FINAL DECISION TRANSACTION PROCESSED BY IB
Saturday, April 13, 2013NEW REPRESENTATIVE AT IB RECEIVED
Saturday, February 23, 2013CHANGE OF NAME/ADDRESS REC'D FROM IB
Tuesday, June 29, 2010FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, June 29, 2010FINAL DISPOSITION PROCESSED
Thursday, June 10, 2010FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, March 9, 2010REGISTERED-PRINCIPAL REGISTER
Tuesday, December 22, 2009OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 22, 2009PUBLISHED FOR OPPOSITION
Thursday, November 19, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, November 18, 2009ASSIGNED TO LIE
Friday, October 30, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, October 30, 2009EXAMINER'S AMENDMENT ENTERED
Friday, October 30, 2009NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, October 30, 2009EXAMINERS AMENDMENT E-MAILED
Friday, October 30, 2009EXAMINERS AMENDMENT -WRITTEN
Saturday, October 3, 2009REFUSAL PROCESSED BY IB
Monday, September 21, 2009ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, September 21, 2009TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, August 28, 2009NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, August 28, 2009REFUSAL PROCESSED BY MPU
Wednesday, August 26, 2009NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, August 25, 2009NON-FINAL ACTION WRITTEN
Saturday, August 22, 2009APPLICATION FILING RECEIPT MAILED
Tuesday, August 18, 2009ASSIGNED TO EXAMINER
Tuesday, August 18, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, August 17, 2009LIMITATION OF GOODS/SERVICES FROM IB ENTERED
Thursday, August 13, 2009SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

irzion preparations system pharmaceutical treatment disorders diseases prevention bacterial diabetes ophthalmology